ENSG00000182054 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000182054 -1.0 7.09e-31 KIRC
ENSG00000182054 -1.1 8.00e-22 HNSC
ENSG00000182054 1.43 9.80e-58 BRCA
ENSG00000182054 1.30 7.19e-37 LUSC
ENSG00000182054 -1.3 5.72e-15 KIRP
ENSG00000182054 2.18 3.17e-51 UCEC
ENSG00000182054 1.17 2.88e-25 LUAD
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000182054 tumors 19228619
ENSG00000182054 tumors 19554337
ENSG00000182054 tumor 19765000
ENSG00000182054 tumors 19915015
ENSG00000182054 tumors 19996293
ENSG00000182054 tumors 20130071
ENSG00000182054 tumor 20131059
ENSG00000182054 AML 20142433
ENSG00000182054 Cancer 20160062
ENSG00000182054 thyroid cancer 20171178
ENSG00000182054 Cancer 20368543
ENSG00000182054 acute myeloid leukemia (AML) 20421455
ENSG00000182054 tumors 20427748
ENSG00000182054 AML 20428194
ENSG00000182054 tumor 20441611
ENSG00000182054 tumors 20473936
ENSG00000182054 acute myeloid leukemia (AML) 20508616
ENSG00000182054 cancers 20513808
ENSG00000182054 acute myeloid leukemia (AML) 20538800
ENSG00000182054 acute myeloid leukemia (AML) 20567020
ENSG00000182054 tumors 20603105
ENSG00000182054 acute myeloid leukemia (AML) 20625116
ENSG00000182054 acute myeloid leukemia (AML) 20692206
ENSG00000182054 tumor 20714900
ENSG00000182054 tumors 20725730
ENSG00000182054 tumor 20872044
ENSG00000182054 acute myeloid leukemia (AML) 20946881
ENSG00000182054 acute myeloid leukemia (AML) 20962328
ENSG00000182054 acute myeloid leukemia (AML) 21079611
ENSG00000182054 cancers 21080253
ENSG00000182054 tumors 21163902
ENSG00000182054 acute myeloid leukemia (AML) 21173122
ENSG00000182054 AML 21205756
ENSG00000182054 Wilms tumors 21225914
ENSG00000182054 tumors 21246521
ENSG00000182054 tumor 21251613
ENSG00000182054 cancer 21284999
ENSG00000182054 AML 21301796
ENSG00000182054 tumors 21317451
ENSG00000182054 cancer 21326614
ENSG00000182054 tumors 21356389
ENSG00000182054 tumors 21378543
ENSG00000182054 glial tumors 21479234
ENSG00000182054 pediatric AML 21504050
ENSG00000182054 oligodendroglial tumors 21554053
ENSG00000182054 Tumors 21575270
ENSG00000182054 AML 21596848
ENSG00000182054 tumours 21598255
ENSG00000182054 tumours 21625441
ENSG00000182054 cancer 21641335
ENSG00000182054 brain tumors 21643842
ENSG00000182054 glial tumors 21643985
ENSG00000182054 AML 21647152
ENSG00000182054 AMLs 21647154
ENSG00000182054 cancer 21801601
ENSG00000182054 AML 21867611
ENSG00000182054 tumor 21874255
ENSG00000182054 AML 21881046
ENSG00000182054 acute myeloid leukemia (AML) 21889610
ENSG00000182054 AML 21912393
ENSG00000182054 tumor 21913188
ENSG00000182054 acute myeloid leukemia (AML) 21997850
ENSG00000182054 brain cancers 22015945
ENSG00000182054 acute myeloid leukemia (AML) 22020636
ENSG00000182054 oligodendroglial tumors 22020830
ENSG00000182054 tumors 22057234
ENSG00000182054 tumor 22057236
ENSG00000182054 cancer 22080945
ENSG00000182054 tumor 22084619
ENSG00000182054 tumor 22105553
ENSG00000182054 tumor 22162831
ENSG00000182054 cancer 22166000
ENSG00000182054 tumor 22180306
ENSG00000182054 tumor 22215888
ENSG00000182054 tumor 22281806
ENSG00000182054 tumors 22287028
ENSG00000182054 Wilms tumor 22289988
ENSG00000182054 tumor 22309944
ENSG00000182054 acute myeloid leukemia (AML) 22338155
ENSG00000182054 tumours 22343896
ENSG00000182054 AML 22343901
ENSG00000182054 cancers 22385606
ENSG00000182054 AML 22389883
ENSG00000182054 cancer 22391998
ENSG00000182054 acute myeloid leukemia (AML) 22397365
ENSG00000182054 breast cancer 22414580
ENSG00000182054 cancer 22416140
ENSG00000182054 cancer 22442146
ENSG00000182054 AML 22507776
ENSG00000182054 tumors 22528790
ENSG00000182054 tumor 22533343
ENSG00000182054 Cancer 22535206
ENSG00000182054 acute myeloid leukemia (AML) 22616558
ENSG00000182054 oligodendroglial tumors 22617234
ENSG00000182054 neuronal tumors 22627626
ENSG00000182054 cancer 22675360
ENSG00000182054 AML 22691121
ENSG00000182054 tumour 22712628
ENSG00000182054 AML 22763442
ENSG00000182054 tumours 22771539
ENSG00000182054 acute myeloid leukemia (AML) 22781800
ENSG00000182054 tumor 22823977
ENSG00000182054 GBM 22824796
ENSG00000182054 tumors 22865003
ENSG00000182054 tumors 22869205
ENSG00000182054 cartilaginous tumors 22885298
ENSG00000182054 astrocytic tumors 22886134
ENSG00000182054 AML 22898539
ENSG00000182054 oligodendroglial tumors 22922872
ENSG00000182054 tumors 22945948
ENSG00000182054 tumors of the nervous system 22966399
ENSG00000182054 tumor 22980977
ENSG00000182054 tumor 23047041
ENSG00000182054 AML 23056961
ENSG00000182054 cancer 23071355
ENSG00000182054 tumors 23071358
ENSG00000182054 tumor 23071531
ENSG00000182054 acute myeloid leukemia (AML) 23074281
ENSG00000182054 brain tumors 23111198
ENSG00000182054 tumors 23161787
ENSG00000182054 GBMs 23226047
ENSG00000182054 colon cancer 23226729
ENSG00000182054 tumors 23232569
ENSG00000182054 AML 23233047
ENSG00000182054 tumours 23250732
ENSG00000182054 tumors 23263745
ENSG00000182054 cancers 23264629
ENSG00000182054 tumor 23267435
ENSG00000182054 tumors 23376717
ENSG00000182054 cancers 23393090
ENSG00000182054 AML 23471017
ENSG00000182054 tumors 23524262
ENSG00000182054 tumor 23533770
ENSG00000182054 tumours 23545860
ENSG00000182054 cancers 23558173
ENSG00000182054 cancer 23561848
ENSG00000182054 mesenchymal tumors 23598960
ENSG00000182054 cancers 23604282
ENSG00000182054 AML 23613679
ENSG00000182054 cancer 23630074
ENSG00000182054 AML 23640996
ENSG00000182054 tumor 23671639
ENSG00000182054 tumor 23680144
ENSG00000182054 acute myeloid leukemia (AML) 23755812
ENSG00000182054 cartilaginous tumors 23782684
ENSG00000182054 tumors 23793099
ENSG00000182054 AML-M5 23815907
ENSG00000182054 tumor 23826216
ENSG00000182054 tumors 23840696
ENSG00000182054 AML 23847760
ENSG00000182054 tumour 23863747
ENSG00000182054 tumor 23877318
ENSG00000182054 acute myeloid leukemia (AML) 23949315
ENSG00000182054 thyroid cancer 23954893
ENSG00000182054 tumour 23998913
ENSG00000182054 Cancer 24065765
ENSG00000182054 GBMs 24077805
ENSG00000182054 acute myeloid leukemia (AML) 24082129
ENSG00000182054 oligodendroglial tumors 24083241
ENSG00000182054 oligodendroglial tumor 24086756
ENSG00000182054 AML 24127214
ENSG00000182054 cancer 24132108
ENSG00000182054 cancer 24133372
ENSG00000182054 cancer 24172328
ENSG00000182054 tumor 24184969
ENSG00000182054 tumors 24204165
ENSG00000182054 tumor 24240089
ENSG00000182054 tumor 24252742
ENSG00000182054 AMLs 24280869
ENSG00000182054 tumors 24295421
ENSG00000182054 acute myeloid leukemia (AML) 24309525
ENSG00000182054 germ cell cancer 24386123
ENSG00000182054 tumor 24403254
ENSG00000182054 acute myeloid leukemia (AML) 24440599
ENSG00000182054 acute myeloid leukemia (AML) 24443894
ENSG00000182054 tumor 24457079
ENSG00000182054 tumor 24460285
ENSG00000182054 tumor 24478380
ENSG00000182054 GBM 24511544
ENSG00000182054 Tumors 24569570
ENSG00000182054 tumor 24581008
ENSG00000182054 tumors 24589777
ENSG00000182054 AML 24590286
ENSG00000182054 cartilaginous tumors 24680178
ENSG00000182054 tumor 24716838
ENSG00000182054 astrocytic tumors 24810474
ENSG00000182054 cancers 24867389
ENSG00000182054 tumor 24877111
ENSG00000182054 acute myeloid leukemia (AML) 24880135
ENSG00000182054 AML 24887327
ENSG00000182054 colorectal cancer 24887488
ENSG00000182054 tumor 24932255
ENSG00000182054 tumours 24952577
ENSG00000182054 tumor 24980596
ENSG00000182054 acute myeloid leukemia (AML) 24986689
ENSG00000182054 AML 24989313
ENSG00000182054 cancers 24995286
ENSG00000182054 AML-M0 25022553
ENSG00000182054 liver cancer 25043045
ENSG00000182054 tumor 25086359
ENSG00000182054 tumor 25091696
ENSG00000182054 tumor 25098926
ENSG00000182054 tumor 25102416
ENSG00000182054 cancer 25111821
ENSG00000182054 AML 25126540
ENSG00000182054 GBM 25140280
ENSG00000182054 cancers 25159915
ENSG00000182054 tumors 25182153
ENSG00000182054 tumor 25185240
ENSG00000182054 AML 25232952
ENSG00000182054 tumors 25257301
ENSG00000182054 AML 25324972
ENSG00000182054 Cancer 25391653
ENSG00000182054 GBM 25392408
ENSG00000182054 Cancer 25398938
ENSG00000182054 cancers 25398939
ENSG00000182054 cancer 25398940
ENSG00000182054 acute myeloid leukemia (AML) 25412851
ENSG00000182054 tumours 25432631
ENSG00000182054 cancer 25469243
ENSG00000182054 AML 25482556
ENSG00000182054 bone tumors 25485496
ENSG00000182054 acute myeloid leukemia (AML) 25486927
ENSG00000182054 GBMs 25495392
ENSG00000182054 tumors 25496513
ENSG00000182054 tumor 25502799
ENSG00000182054 AML 25523507
ENSG00000182054 tumor 25552286
ENSG00000182054 AML 25599133
ENSG00000182054 acute myeloid leukemia (AML) 25601757
ENSG00000182054 GBM 25631659
ENSG00000182054 AML 25632305
ENSG00000182054 AML 25651001
ENSG00000182054 tumor 25694352
ENSG00000182054 tumor 25722939
ENSG00000182054 primary brain tumors 25727224
ENSG00000182054 tumor 25730874
ENSG00000182054 tumors 25753205
ENSG00000182054 AML 25765792
ENSG00000182054 cancers 25766404
ENSG00000182054 cancer 25787993
ENSG00000182054 cancers 25795706
ENSG00000182054 tumors 25797251
ENSG00000182054 vulva tumors 25823555
ENSG00000182054 cancer 25825982
ENSG00000182054 cancer 25883647
ENSG00000182054 tumors 25895133
ENSG00000182054 AML 25924101
ENSG00000182054 cancers 25956465
ENSG00000182054 AML 25960660
ENSG00000182054 oligodendroglial tumors 25989737
ENSG00000182054 giant cell tumors 26018518
ENSG00000182054 cancer 26024390
ENSG00000182054 cancer 26041263
ENSG00000182054 tumors 26046462
ENSG00000182054 tumours 26068201
ENSG00000182054 acute myeloid leukemia (AML) 26110659
ENSG00000182054 AML 26111463
ENSG00000182054 AML 26111466
ENSG00000182054 breast cancer 26113877
ENSG00000182054 tumors 26147657
ENSG00000182054 tumors 26170993
ENSG00000182054 cancer 26178471
ENSG00000182054 acute myeloid leukemia (AML) 26189213
ENSG00000182054 AML 26230955
ENSG00000182054 AML 26239249
ENSG00000182054 cancers 26251629
ENSG00000182054 GBM 26264438
ENSG00000182054 AML 26345565
ENSG00000182054 tumor 26368816
ENSG00000182054 AML 26375248
ENSG00000182054 giant cell tumor of bone 26457357
ENSG00000182054 AML 26486081
ENSG00000182054 oligodendroglial tumors 26509217
ENSG00000182054 tumors 26553362
ENSG00000182054 AML 26553750
ENSG00000182054 Mast Cell Tumors 26562302
ENSG00000182054 Cancer 26568194
ENSG00000182054 AML 26582645
ENSG00000182054 tumour 26635288
ENSG00000182054 tumors 26646705
ENSG00000182054 cancer 26660517
ENSG00000182054 tumors 26669865
ENSG00000182054 tumor 26673168
ENSG00000182054 tumor 26697989
ENSG00000182054 tumors 26699864
ENSG00000182054 cancers 26761588
ENSG00000182054 acute myeloid leukemia (AML) 26789100
ENSG00000182054 AML 26796102
ENSG00000182054 AML 26812887
ENSG00000182054 acute myeloid leukemia (AML) 26819452
ENSG00000182054 tumor 26820720
ENSG00000182054 tumors 26834160
ENSG00000182054 lymph node tumors 26852708
ENSG00000182054 cancer 26898144
ENSG00000182054 tumor 26920730
ENSG00000182054 Cancer 26943899
ENSG00000182054 glial tumors 26945349
ENSG00000182054 tumors 26948350
ENSG00000182054 tumors 26948489
ENSG00000182054 cancer 26956544
ENSG00000182054 AML 26959069
ENSG00000182054 GBMs 26975364
ENSG00000182054 tumors 26990854
ENSG00000182054 acute myeloid leukemia (AML) 27005468
ENSG00000182054 tumors 27014623
ENSG00000182054 AML 27023522
ENSG00000182054 tumors 27036230
ENSG00000182054 malignant tumors 27050164
ENSG00000182054 Breast cancer 27081087
ENSG00000182054 tumor 27087448
ENSG00000182054 tumors 27097804
ENSG00000182054 AML with recurrent genetic abnormalities 27137476
ENSG00000182054 AML 27144061
ENSG00000182054 AML 27196610
ENSG00000182054 cancer 27245697
ENSG00000182054 tumor 27268645
ENSG00000182054 AML 27276561
ENSG00000182054 cancers 27292784
ENSG00000182054 tumors 27311324
ENSG00000182054 AML 27316347
ENSG00000182054 AML-M2 27352183
ENSG00000182054 tumors 27353503
ENSG00000182054 cancers 27355333
ENSG00000182054 AML 27359055
ENSG00000182054 tumor 27386546
ENSG00000182054 AML 27389053
ENSG00000182054 cancers 27427385
ENSG00000182054 ovarian tumors 27446471
ENSG00000182054 primary brain tumors 27454254
ENSG00000182054 AML 27458708
ENSG00000182054 cartilaginous tumors 27461824
ENSG00000182054 gastric cancer 27466503
ENSG00000182054 tumours 27499898
ENSG00000182054 AMLs 27534895
ENSG00000182054 AML 27548812
ENSG00000182054 tumors 27553275
ENSG00000182054 tumor 27568302
ENSG00000182054 AML 27575502
ENSG00000182054 AML 27577048
ENSG00000182054 tumors 27591990
ENSG00000182054 cancers 27621679
ENSG00000182054 cancer 27635066
ENSG00000182054 lung cancer 27649069
ENSG00000182054 AML 27684276
ENSG00000182054 AML 27752467
ENSG00000182054 Tumors 27774467
ENSG00000182054 GBM 27787518
ENSG00000182054 AML 27806325
ENSG00000182054 Tumors 27852048
ENSG00000182054 tumours 27886174
ENSG00000182054 AML 27899806
ENSG00000182054 AML 27904446
ENSG00000182054 Breast Cancer 27913435
ENSG00000182054 glial tumors 27923049
ENSG00000182054 tumor 27956631
ENSG00000182054 tumors 27982681
ENSG00000182054 HNSCC 28053877
ENSG00000182054 AML 28074068
ENSG00000182054 tumor 28084339
ENSG00000182054 AML 28096533
ENSG00000182054 tumors 28098230
ENSG00000182054 tumor 28122345
ENSG00000182054 cancer 28132785
ENSG00000182054 AML 28152414
ENSG00000182054 AML 28154779
ENSG00000182054 tumor 28157189
ENSG00000182054 AML 28167833
ENSG00000182054 cancer 28168295
ENSG00000182054 Cancer 28193778
ENSG00000182054 acute myeloid leukemias (AML) 28193779
ENSG00000182054 AML 28197208
ENSG00000182054 tumors 28228392
ENSG00000182054 AML 28246275
ENSG00000182054 tumors 28316990
ENSG00000182054 AML 28325290
ENSG00000182054 AML 28345823
ENSG00000182054 cancers 28373964
ENSG00000182054 cancer 28401022
ENSG00000182054 cartilaginous tumors 28410203
ENSG00000182054 AML 28461409
ENSG00000182054 breast cancer 28521409
ENSG00000182054 tumors 28525363
ENSG00000182054 GBMs 28535583
ENSG00000182054 Cancer 28536275
ENSG00000182054 giant cell tumor of bone 28545165
ENSG00000182054 cartilaginous tumors 28552826
ENSG00000182054 cancer 28554049
ENSG00000182054 GBM 28564604
ENSG00000182054 AML 28588019
ENSG00000182054 acute myeloid leukemia (AML) 28588020
ENSG00000182054 tumours 28601826
ENSG00000182054 tumors 28634614
ENSG00000182054 cancer 28649560
ENSG00000182054 Cancer 28653623
ENSG00000182054 tumors 28675510
ENSG00000182054 tumors of the central nervous system 28748342
ENSG00000182054 tumors 28748451
ENSG00000182054 tumors 28785398
ENSG00000182054 tumors 28785587
ENSG00000182054 tumors 28797501
ENSG00000182054 skin cancers 28806730
ENSG00000182054 cancers 28827794
ENSG00000182054 AML 28851395
ENSG00000182054 bone tumor 28860121
ENSG00000182054 AML 28879540
ENSG00000182054 tumor 28889481
ENSG00000182054 gallbladder cancer 28900470
ENSG00000182054 tumor 28915660
ENSG00000182054 tumor 28939851
ENSG00000182054 AML 28986582
ENSG00000182054 acute myeloid leukemia (AML) 29051180
ENSG00000182054 AML 29062039
ENSG00000182054 tumour 29098416
ENSG00000182054 AML 29156201
ENSG00000182054 AML 29166738
ENSG00000182054 cancers 29184081
ENSG00000182054 cancer 29216518
ENSG00000182054 tumors 29238848
ENSG00000182054 AML 29270125
ENSG00000182054 tumors 29272308
ENSG00000182054 AML 29278535
ENSG00000182054 AML 29283906
ENSG00000182054 cancer 29287594
ENSG00000182054 GBMs 29290954
ENSG00000182054 AML 29301553
ENSG00000182054 AML 29326930
ENSG00000182054 AML 29327808
ENSG00000182054 tumors 29339485
ENSG00000182054 cancer 29342092
ENSG00000182054 AML 29343972
ENSG00000182054 acute myeloid leukemia (AML) 29346478
ENSG00000182054 AML 29367755
ENSG00000182054 AML 29402726
ENSG00000182054 breast cancer 29413657
ENSG00000182054 cancer 29434842
ENSG00000182054 AML 29435155
ENSG00000182054 tumor 29439493
ENSG00000182054 tumors 29444314
ENSG00000182054 tumors 29458964
ENSG00000182054 non-small-cell lung cancer 29465809
ENSG00000182054 tumor 29499756
ENSG00000182054 GBM 29511362
ENSG00000182054 AML 29527516
ENSG00000182054 brain tumors 29535392
ENSG00000182054 acute myeloid leukemia (AML) 29543066
ENSG00000182054 brain tumors 29567975
ENSG00000182054 bone tumour 29576625
ENSG00000182054 tumours 29581779
ENSG00000182054 Tumour 29603332
ENSG00000182054 AML 29607374
ENSG00000182054 tumor 29615461
ENSG00000182054 AML 29622865
ENSG00000182054 AML 29625580
ENSG00000182054 tumor 29631562
ENSG00000182054 breast cancer 29661250
ENSG00000182054 AML 29661468
ENSG00000182054 tumors 29662631
ENSG00000182054 GBM 29662659
ENSG00000182054 tumors 29718398
ENSG00000182054 GBM 29719265
ENSG00000182054 AML 29727824
ENSG00000182054 AML 29750014
ENSG00000182054 tumors 29760106
ENSG00000182054 Cancer 29769206
ENSG00000182054 AML 29770715
ENSG00000182054 tumors 29773061
ENSG00000182054 tumors 29784746
ENSG00000182054 breast tumor 29785016
ENSG00000182054 cancers 29788892
ENSG00000182054 tumors 29805076
ENSG00000182054 glial tumors 29863707
ENSG00000182054 tumor 29884741
ENSG00000182054 cancer 29888201
ENSG00000182054 DLBCL 29895903
ENSG00000182054 AML 29950729
ENSG00000182054 tumors 29967940
ENSG00000182054 tumor 29981867
ENSG00000182054 cancers 29987482
ENSG00000182054 AML 29988143
ENSG00000182054 acute myeloid leukemia (AML) 30013198
ENSG00000182054 tumors 30069631
ENSG00000182054 Tumor 30107580
ENSG00000182054 AML 30122995
ENSG00000182054 AML 30122998
ENSG00000182054 cancer 30128035
ENSG00000182054 tumors 30131249
ENSG00000182054 AML 30135719
ENSG00000182054 tumor 30158952
ENSG00000182054 cancer 30170631
ENSG00000182054 tumors 30196423
ENSG00000182054 tumors 30206411
ENSG00000182054 AML 30209701
ENSG00000182054 cancer 30231564
ENSG00000182054 tumor 30253794
ENSG00000182054 tumors 30279357
ENSG00000182054 tumors 30296521
ENSG00000182054 AML 30305501
ENSG00000182054 cancers 30355481
ENSG00000182054 tumors 30355724
ENSG00000182054 tumor 30360730
ENSG00000182054 tumors 30375429
ENSG00000182054 tumors 30386625
ENSG00000182054 Acute myeloid leukemia (AML) 30422308
ENSG00000182054 AML 30423907
ENSG00000182054 tumor 30455381
ENSG00000182054 AML 30455953
ENSG00000182054 AML 30466744
ENSG00000182054 AML 30477280
ENSG00000182054 tumors 30483760
ENSG00000182054 cancers 30506321
ENSG00000182054 acute myeloid leukemia (AML) 30510081
ENSG00000182054 AML 30514804
ENSG00000182054 tumours 30582658
ENSG00000182054 cancer 30613765
ENSG00000182054 tumor 30615206
ENSG00000182054 GBMs 30625996
ENSG00000182054 AML 30626126
ENSG00000182054 AML 30643428
ENSG00000182054 AML 30664659
ENSG00000182054 tumor 30675060
ENSG00000182054 tumors 30708988
ENSG00000182054 acute myeloid leukemia (AML) 30728456
ENSG00000182054 tumours 30786920
ENSG00000182054 AML 30795628
ENSG00000182054 GBM 30811476
ENSG00000182054 AML 30813354
ENSG00000182054 cancers 30823893
ENSG00000182054 AML 30857299
ENSG00000182054 AML 30861214
ENSG00000182054 AML 30896832
ENSG00000182054 Cancer 30922328
ENSG00000182054 AML 30935386
ENSG00000182054 tumor 30936198
ENSG00000182054 AML 30945331
ENSG00000182054 tumors 30948495
ENSG00000182054 tumors 30958073
ENSG00000182054 tumor 30967140
ENSG00000182054 AML 30972998
ENSG00000182054 AML 30984620
ENSG00000182054 tumor 30987403
ENSG00000182054 AML 31004016
ENSG00000182054 cancers 31010244
ENSG00000182054 AML 31018543
ENSG00000182054 prostate cancer 31068457
ENSG00000182054 AML 31085507
ENSG00000182054 tumors 31105869
ENSG00000182054 AML 31109331
ENSG00000182054 tumours 31114017
ENSG00000182054 thyroid cancer 31118795
ENSG00000182054 AML 31118877
ENSG00000182054 Cancer 31131326
ENSG00000182054 cancer 31139406
ENSG00000182054 AML 31163594
ENSG00000182054 AML 31165048
ENSG00000182054 tumors 31186531
ENSG00000182054 AML 31190985
ENSG00000182054 tumor 31212687
ENSG00000182054 tumours 31217897
ENSG00000182054 cancer 31221981
ENSG00000182054 AML 31236772
ENSG00000182054 AML 31236919
ENSG00000182054 tumor 31257503
ENSG00000182054 tumors 31263678
ENSG00000182054 cancers 31277295
ENSG00000182054 tumor 31291378
ENSG00000182054 Cancer 31303761
ENSG00000182054 AML 31319822
ENSG00000182054 AML 31321011
ENSG00000182054 tumors 31328403
ENSG00000182054 AML 31331874
ENSG00000182054 AML 31348835
ENSG00000182054 cancers 31361380
ENSG00000182054 AML 31366466
ENSG00000182054 granulosa cell tumors 31409083
ENSG00000182054 AML 31413655
ENSG00000182054 acute myeloid leukemia(AML) 31418360
ENSG00000182054 AML 31431820
ENSG00000182054 AML 31447578
ENSG00000182054 AML 31450562
ENSG00000182054 tumor 31455412
ENSG00000182054 AML 31467542
ENSG00000182054 AML 31478278
ENSG00000182054 cancer 31530011
ENSG00000182054 AML 31533852
ENSG00000182054 AML 31540291
ENSG00000182054 AMLs 31547472
ENSG00000182054 AML 31564968
ENSG00000182054 tumor 31569444
ENSG00000182054 tumor 31581674
ENSG00000182054 breast cancer 31599393
ENSG00000182054 GBMs 31604779
ENSG00000182054 AML 31606046
ENSG00000182054 tumor 31612017
ENSG00000182054 GBM 31623667
ENSG00000182054 AML 31632056
ENSG00000182054 AML 31660152
ENSG00000182054 AML 31670197
ENSG00000182054 pediatric AML 31681706
ENSG00000182054 AML 31690995
ENSG00000182054 AML 31692757
ENSG00000182054 AML 31723801
ENSG00000182054 tumor 31727977
ENSG00000182054 tumours 31728625
ENSG00000182054 AML 31740742
ENSG00000182054 AML 31762818
ENSG00000182054 tumor 31771970
ENSG00000182054 tumours 31795195
ENSG00000182054 tumors 31833906
ENSG00000182054 AML 31835432
ENSG00000182054 cancer 31847543
ENSG00000182054 biliary tract cancer 31908303
ENSG00000182054 AML 31921515
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000182054 myelodysplastic syndrome sequence_alteration 3.981% (135/3391) 13 entries
ENSG00000182054 Sinonasal Undifferentiated Carcinoma missense_variant 78.95% (15/19) 2 entries
ENSG00000182054 myelodysplastic syndrome missense_variant 3.981% (135/3391) 26 entries
ENSG00000182054 angioimmunoblastic T-cell lymphoma missense_variant 23.99% (95/396) 11 entries
ENSG00000182054 angioimmunoblastic T-cell lymphoma sequence_alteration 23.99% (95/396) 9 entries
ENSG00000182054 anaplastic oligodendroglioma sequence_alteration 6.03% (36/597) 7 entries
ENSG00000182054 acute myeloid leukemia missense_variant 9.39% (1465/15602) 74 entries
ENSG00000182054 anaplastic oligodendroglioma missense_variant 6.03% (36/597) 15 entries
ENSG00000182054 acute myeloid leukemia sequence_alteration 9.39% (1465/15602) 46 entries
ENSG00000182054 myeloproliferative disorder missense_variant 1.748% (5/286) 4 entries
ENSG00000182054 polycythemia vera sequence_alteration 1.918% (15/782) 3 entries
ENSG00000182054 chronic myelomonocytic leukemia missense_variant 5.042% (30/595) 11 entries
ENSG00000182054 unspecified peripheral T-cell lymphoma sequence_alteration 2.591% (5/193) 2 entries
ENSG00000182054 clear cell renal carcinoma sequence_alteration 0.1855% (3/1617) 2 entries
ENSG00000182054 anaplastic oligodendroglioma frameshift_variant 6.03% (36/597) 1 entry
ENSG00000182054 colon adenocarcinoma missense_variant 0.6588% (10/1518) 3 entries
ENSG00000182054 myelodysplastic syndrome stop_gained 3.981% (135/3391) 1 entry
ENSG00000182054 glioma missense_variant 2.065% (71/3438) 12 entries
ENSG00000182054 T-cell acute lymphoblastic leukemia frameshift_variant 0.5917% (4/676) 1 entry
ENSG00000182054 Endometrial Endometrioid Adenocarcinoma missense_variant 1.231% (8/650) 1 entry
ENSG00000182054 chronic myelomonocytic leukemia sequence_alteration 5.042% (30/595) 7 entries
ENSG00000182054 colorectal adenocarcinoma frameshift_variant 1.4% (31/2215) 2 entries
ENSG00000182054 anaplastic astrocytoma sequence_alteration 0.7785% (9/1156) 4 entries
ENSG00000182054 gastric adenocarcinoma missense_variant 0.3729% (5/1341) 2 entries
ENSG00000182054 essential thrombocythemia sequence_alteration 0.5613% (6/1069) 3 entries
ENSG00000182054 astrocytoma sequence_alteration 0.974% (3/308) 2 entries
ENSG00000182054 melanoma missense_variant 1.894% (5/264) 2 entries
ENSG00000182054 anaplastic oligoastrocytoma sequence_alteration 4.197% (23/548) 4 entries
ENSG00000182054 osteosarcoma sequence_alteration 0.7722% (2/259) 1 entry
ENSG00000182054 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive sequence_alteration 3.086% (5/162) 2 entries
ENSG00000182054 diffuse large B-cell lymphoma sequence_alteration 0.3831% (2/522) 2 entries
ENSG00000182054 hemangioblastoma sequence_alteration 16.22% (6/37) 1 entry
ENSG00000182054 colorectal adenocarcinoma sequence_alteration 1.4% (31/2215) 2 entries
ENSG00000182054 brain glioblastoma missense_variant 0.2628% (12/4567) 9 entries
ENSG00000182054 breast carcinoma missense_variant 0.08446% (2/2368) 1 entry
ENSG00000182054 anaplastic astrocytoma missense_variant 0.7785% (9/1156) 7 entries
ENSG00000182054 chronic myelogenous leukemia sequence_alteration 0.4405% (2/454) 2 entries
ENSG00000182054 colon adenocarcinoma sequence_alteration 0.6588% (10/1518) 2 entries
ENSG00000182054 T-cell acute lymphoblastic leukemia sequence_alteration 0.5917% (4/676) 3 entries
ENSG00000182054 Myelodysplastic/Myeloproliferative Neoplasm missense_variant 2.247% (2/89) 1 entry
ENSG00000182054 prostate adenocarcinoma sequence_alteration 0.3445% (8/2322) 1 entry
ENSG00000182054 Uterine Carcinosarcoma sequence_alteration 1.212% (2/165) 1 entry
ENSG00000182054 nasopharyngeal squamous cell carcinoma sequence_alteration 5.519% (17/308) 1 entry
ENSG00000182054 papillary renal cell carcinoma sequence_alteration 0.5155% (2/388) 1 entry
ENSG00000182054 dedifferentiated chondrosarcoma missense_variant 15.56% (7/45) 5 entries
ENSG00000182054 brain glioblastoma sequence_alteration 0.2628% (12/4567) 3 entries
ENSG00000182054 gastric adenocarcinoma sequence_alteration 0.3729% (5/1341) 3 entries
ENSG00000182054 HER2 Positive Breast Carcinoma sequence_alteration 1.449% (2/138) 1 entry
ENSG00000182054 colorectal adenocarcinoma missense_variant 1.4% (31/2215) 2 entries
ENSG00000182054 anaplastic oligoastrocytoma missense_variant 4.197% (23/548) 10 entries
ENSG00000182054 prostate carcinoma sequence_alteration 1.174% (5/426) 1 entry
ENSG00000182054 chronic myelogenous leukemia missense_variant 0.4405% (2/454) 2 entries
ENSG00000182054 T-cell acute lymphoblastic leukemia missense_variant 0.5917% (4/676) 2 entries
ENSG00000182054 rectal adenocarcinoma missense_variant 0.3226% (2/620) 1 entry
ENSG00000182054 bladder transitional cell carcinoma missense_variant 0.7968% (4/502) 3 entries
ENSG00000182054 brain astrocytoma sequence_alteration 3.723% (7/188) 2 entries
ENSG00000182054 oligoastrocytoma missense_variant 3.457% (13/376) 7 entries
ENSG00000182054 esophageal squamous cell carcinoma missense_variant 0.3708% (3/809) 1 entry
ENSG00000182054 polycythemia vera missense_variant 1.918% (15/782) 3 entries
ENSG00000182054 Granulocytic Sarcoma missense_variant 7.143% (2/28) 1 entry
ENSG00000182054 chondroma sequence_alteration 9.091% (5/55) 2 entries
ENSG00000182054 hepatocellular carcinoma missense_variant 1.266% (13/1027) 2 entries
ENSG00000182054 ganglioglioma sequence_alteration 2.013% (3/149) 1 entry
ENSG00000182054 acute myeloid leukemia frameshift_variant 9.39% (1465/15602) 1 entry
ENSG00000182054 Granulocytic Sarcoma sequence_alteration 7.143% (2/28) 1 entry
ENSG00000182054 chondrosarcoma sequence_alteration 6.452% (10/155) 4 entries
ENSG00000182054 skin melanoma sequence_alteration 0.6325% (10/1581) 5 entries
ENSG00000182054 chondroma missense_variant 9.091% (5/55) 3 entries
ENSG00000182054 dedifferentiated chondrosarcoma sequence_alteration 15.56% (7/45) 2 entries
ENSG00000182054 Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive missense_variant 3.086% (5/162) 2 entries
ENSG00000182054 clear cell renal carcinoma missense_variant 0.1855% (3/1617) 2 entries
ENSG00000182054 lung adenocarcinoma missense_variant 0.2223% (6/2699) 3 entries
ENSG00000182054 bile duct adenocarcinoma missense_variant 2.598% (39/1501) 10 entries
ENSG00000182054 prostate adenocarcinoma missense_variant 0.3445% (8/2322) 2 entries
ENSG00000182054 breast ductal adenocarcinoma missense_variant 0.8378% (14/1671) 1 entry
ENSG00000182054 osteosarcoma missense_variant 0.7722% (2/259) 1 entry
ENSG00000182054 glioma sequence_alteration 2.065% (71/3438) 8 entries
ENSG00000182054 brain astrocytoma missense_variant 3.723% (7/188) 2 entries
ENSG00000182054 pancreatic ductal adenocarcinoma sequence_alteration 0.3504% (7/1998) 1 entry
ENSG00000182054 colon adenocarcinoma stop_gained 0.6588% (10/1518) 2 entries
ENSG00000182054 breast ductal adenocarcinoma sequence_alteration 0.8378% (14/1671) 1 entry
ENSG00000182054 chondrosarcoma missense_variant 6.452% (10/155) 4 entries
ENSG00000182054 essential thrombocythemia missense_variant 0.5613% (6/1069) 3 entries
ENSG00000182054 nasal cavity and paranasal sinus carcinoma missense_variant 11.11% (3/27) 1 entry
ENSG00000182054 oligoastrocytoma sequence_alteration 3.457% (13/376) 4 entries
ENSG00000182054 squamous cell lung carcinoma missense_variant 0.2086% (2/959) 1 entry
ENSG00000182054 rectal adenocarcinoma sequence_alteration 0.3226% (2/620) 1 entry
ENSG00000182054 Endometrial Endometrioid Adenocarcinoma sequence_alteration 1.231% (8/650) 1 entry
ENSG00000182054 urothelial carcinoma sequence_alteration 3.488% (3/86) 1 entry
ENSG00000182054 astrocytoma missense_variant 0.974% (3/308) 3 entries
ENSG00000182054 skin melanoma missense_variant 0.6325% (10/1581) 5 entries
ENSG00000182054 Sinonasal Undifferentiated Carcinoma sequence_alteration 78.95% (15/19) 1 entry
ENSG00000182054 nasopharyngeal squamous cell carcinoma missense_variant 5.519% (17/308) 2 entries
ENSG00000182054 bile duct adenocarcinoma sequence_alteration 2.598% (39/1501) 8 entries
ENSG00000182054 unspecified peripheral T-cell lymphoma missense_variant 2.591% (5/193) 2 entries
ENSG00000182054 urothelial carcinoma missense_variant 3.488% (3/86) 1 entry
ENSG00000182054 rectal adenocarcinoma frameshift_variant 0.3226% (2/620) 1 entry
ENSG00000182054 breast carcinoma sequence_alteration 0.08446% (2/2368) 1 entry
ENSG00000182054 in situ carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000182054 pancreatic ductal adenocarcinoma missense_variant 0.3504% (7/1998) 1 entry
ENSG00000182054 hepatocellular carcinoma stop_gained 1.266% (13/1027) 1 entry
ENSG00000182054 Bladder Adenocarcinoma sequence_alteration 4.545% (1/22) 1 entry
ENSG00000182054 basal cell carcinoma sequence_alteration 1.408% (1/71) 1 entry
ENSG00000182054 lymphoid neoplasm missense_variant 0.3484% (1/287) 1 entry
ENSG00000182054 epidermal appendage tumor missense_variant 14.29% (1/7) 1 entry
ENSG00000182054 Ocular Sebaceous Carcinoma missense_variant 4.167% (1/24) 1 entry
ENSG00000182054 lobular breast carcinoma sequence_alteration 0.3831% (1/261) 1 entry
ENSG00000182054 Bladder Adenocarcinoma missense_variant 4.545% (1/22) 1 entry
ENSG00000182054 Breast Carcinoma by Gene Expression Profile sequence_alteration 1.042% (1/96) 1 entry
ENSG00000182054 nodular melanoma missense_variant 7.692% (1/13) 1 entry
ENSG00000182054 mucosal melanoma sequence_alteration 1.299% (1/77) 1 entry
ENSG00000182054 basal cell carcinoma missense_variant 1.408% (1/71) 1 entry
ENSG00000182054 chronic myelomonocytic leukemia frameshift_variant 5.042% (30/595) 1 entry
ENSG00000182054 High Grade Surface Osteosarcoma missense_variant 100.0% (1/1) 1 entry
ENSG00000182054 small cell lung carcinoma sequence_alteration 0.2247% (1/445) 1 entry
ENSG00000182054 leiomyosarcoma missense_variant 0.9901% (1/101) 1 entry
ENSG00000182054 ganglioglioma stop_gained 2.013% (3/149) 1 entry
ENSG00000182054 Endometrial Clear Cell Adenocarcinoma sequence_alteration 3.704% (1/27) 1 entry
ENSG00000182054 neoplasm of mature B-cells stop_gained 1.538% (1/65) 1 entry
ENSG00000182054 hemangioma sequence_alteration 14.29% (1/7) 1 entry
ENSG00000182054 B-cell acute lymphoblastic leukemia missense_variant 0.5495% (1/182) 1 entry
ENSG00000182054 oral squamous cell carcinoma missense_variant 0.2778% (1/360) 1 entry
ENSG00000182054 lung carcinoid tumor stop_gained 3.704% (1/27) 1 entry
ENSG00000182054 leiomyosarcoma sequence_alteration 0.9901% (1/101) 1 entry
ENSG00000182054 mucosal melanoma missense_variant 1.299% (1/77) 1 entry
ENSG00000182054 lymphoid neoplasm sequence_alteration 0.3484% (1/287) 1 entry
ENSG00000182054 prostate adenocarcinoma frameshift_variant 0.3445% (8/2322) 1 entry
ENSG00000182054 large cell neuroendocrine carcinoma missense_variant 50.0% (1/2) 1 entry
ENSG00000182054 skin melanoma stop_gained 0.6325% (10/1581) 1 entry
ENSG00000182054 High Grade Surface Osteosarcoma sequence_alteration 100.0% (1/1) 1 entry
ENSG00000182054 sebaceous adenocarcinoma sequence_alteration 12.5% (1/8) 1 entry
ENSG00000182054 neoplasm of mature B-cells sequence_alteration 1.538% (1/65) 1 entry
ENSG00000182054 diffuse large B-cell lymphoma missense_variant 0.3831% (2/522) 1 entry
ENSG00000182054 urothelial carcinoma frameshift_variant 3.488% (3/86) 1 entry
ENSG00000182054 gastric adenocarcinoma frameshift_variant 0.3729% (5/1341) 1 entry
ENSG00000182054 esophageal squamous cell carcinoma frameshift_variant 0.3708% (3/809) 1 entry
ENSG00000182054 HER2 Positive Breast Carcinoma missense_variant 1.449% (2/138) 1 entry
ENSG00000182054 lung carcinoid tumor sequence_alteration 3.704% (1/27) 1 entry
ENSG00000182054 brain glioblastoma stop_gained 0.2628% (12/4567) 1 entry
ENSG00000182054 small intestinal adenocarcinoma sequence_alteration 2.326% (1/43) 1 entry
ENSG00000182054 Endometrial Clear Cell Adenocarcinoma missense_variant 3.704% (1/27) 1 entry
ENSG00000182054 prostate carcinoma frameshift_variant 1.174% (5/426) 1 entry
ENSG00000182054 colon adenocarcinoma frameshift_variant 0.6588% (10/1518) 1 entry
ENSG00000182054 primary peritoneal carcinoma (disease) missense_variant 100.0% (1/1) 1 entry
ENSG00000182054 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma sequence_alteration 0.2288% (1/437) 1 entry
ENSG00000182054 bladder transitional cell carcinoma stop_gained 0.7968% (4/502) 1 entry
ENSG00000182054 Breast Carcinoma by Gene Expression Profile missense_variant 1.042% (1/96) 1 entry
ENSG00000182054 small cell lung carcinoma missense_variant 0.2247% (1/445) 1 entry
ENSG00000182054 Thyroid Gland Undifferentiated (Anaplastic) Carcinoma missense_variant 0.2288% (1/437) 1 entry
ENSG00000182054 Uterine Carcinosarcoma missense_variant 1.212% (2/165) 1 entry
ENSG00000182054 nodular melanoma sequence_alteration 7.692% (1/13) 1 entry
ENSG00000182054 Parotid Gland Carcinoma sequence_alteration 100.0% (1/1) 1 entry
ENSG00000182054 small intestinal adenocarcinoma missense_variant 2.326% (1/43) 1 entry
ENSG00000182054 papillary renal cell carcinoma missense_variant 0.5155% (2/388) 1 entry
ENSG00000182054 cecum adenocarcinoma frameshift_variant 0.3663% (1/273) 1 entry
ENSG00000182054 acute lymphoblastic leukemia missense_variant 0.1181% (1/847) 1 entry
ENSG00000182054 cecum adenocarcinoma sequence_alteration 0.3663% (1/273) 1 entry
ENSG00000182054 epidermal appendage tumor sequence_alteration 14.29% (1/7) 1 entry
ENSG00000182054 hemangioma missense_variant 14.29% (1/7) 1 entry
ENSG00000182054 sebaceous adenocarcinoma missense_variant 12.5% (1/8) 1 entry
ENSG00000182054 gastric intestinal type adenocarcinoma sequence_alteration 1.176% (1/85) 1 entry
ENSG00000182054 gastric intestinal type adenocarcinoma frameshift_variant 1.176% (1/85) 1 entry
ENSG00000182054 Parotid Gland Carcinoma missense_variant 100.0% (1/1) 1 entry
ENSG00000182054 prostate carcinoma missense_variant 1.174% (5/426) 1 entry
ENSG00000182054 melanoma sequence_alteration 1.894% (5/264) 1 entry
ENSG00000182054 Endometrial Endometrioid Adenocarcinoma frameshift_variant 1.231% (8/650) 1 entry
ENSG00000182054 Mantle cell lymphoma sequence_alteration 1.493% (1/67) 1 entry
ENSG00000182054 bladder transitional cell carcinoma sequence_alteration 0.7968% (4/502) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000182054 MESO 0.0019 high
ENSG00000182054 STAD 0.0055 low
ENSG00000182054 CHOL 0.041 high
ENSG00000182054 THCA 0.0046 low
ENSG00000182054 LUSC 0.0058 low
ENSG00000182054 READ 0.049 high
ENSG00000182054 LUAD 0.022 low
ENSG00000182054 THYM 0.039 low
ENSG00000182054 BRCA 0.011 low
ENSG00000182054 COAD 0.05 low
ENSG00000182054 OV 0.027 low
ENSG00000182054 PRAD 0.027 low
ENSG00000182054 BLCA 0.013 high
ENSG00000182054 LIHC 0.047 low
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency
ENSG00000182054 LUSC Amp 1.857290 0.231492 0.464070 0.339321
ENSG00000182054 CESC Amp 1.847321 0.173523 0.555277 0.254237
ENSG00000182054 SKCM Amp 3.184817 0.194604 0.525253 0.324251
ENSG00000182054 BRCA Amp 2.855060 0.183291 0.619195 0.166667
ENSG00000182054 STAD Amp 10.622433 0.337963 0.666877 0.251701
ENSG00000182054 OV Amp 0.602498 0.322412 0.654058 0.240069